CS3002
- Generic Name
- CS3002
A Study of CS3002 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2019-11-14
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- CStone Pharmaceuticals
- Target Recruit Count
- 10
- Registration Number
- NCT04162301
- Locations
- 🇦🇺
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
🇦🇺Peninsula and South Eastern Haematology and Oncology Group, Heidelberg, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath